Fmoc-L-Asn (beta-D-GlcNAc (Ac) 3) -OH
Fmoc-L-Asn (beta-D-GlcNAc (Ac) 3) -OH (Fmoc-Asn (Ac3AcNH-beta-Glc) -OH) can be used in the synthesis of silicon-fluoride acceptor (SiFA) derivatized octreotate derivatives. SiFA-octreotate analogues, as tumor imaging agents, are useful tool for the research of positron emission tomography (PET) [1].
Product Specifications
CAS Number
131287-39-3
Product Name Alternative
Fmoc-Asn (Ac3AcNH-beta-Glc) -OH
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Amino Acid Derivatives
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fmoc-l-asn-beta-d-glcnac-ac-3-oh.html
Purity
95.03
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
CC(N[C@H]([C@H]([C@@H]([C@H](O1)COC(C)=O)OC(C)=O)OC(C)=O)[C@@H]1NC(C[C@@H](C(O)=O)NC(OCC2C3=CC=CC=C3C4=CC=CC=C42)=O)=O)=O
Molecular Formula
C33H37N3O13
Molecular Weight
683.66
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
¹⁸
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
MUC18 / Mucin 18 / CD146 (OJ79c), CF568 conjugate, 0.1mg/mL
